Skip to content

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas: a Randomised, Controlled Trial

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05485038
Acronym
GAMMA
Enrollment
72
Registered
2022-08-02
Start date
2022-09-01
Completion date
2027-08-31
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma, Malignant, Gliomas Benign, Metastases to Brain

Keywords

contrast-enhancing glioma, non-enhancing glioma, brain metastasis, awake surgery, general anesthesia, motor area

Brief summary

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

Detailed description

Awake surgery is usually used for tumor resection located in language areas. But patient's awakening during removal of mass lesions from motor areas can give additional opportunities. Besides checking of muscle contractions and integrity of motor fibers a surgeon in awake patient can assess planning of movements, praxis, visual feedback and vestibular processing of motions. Preserving of voluntary movements can be an additional proof that cortical motor centers and corticospinal tract were not damaged. At the moment there are no published results of randomized trials showing advantage of awake surgery in removal of mass lesions from motor brain areas. Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia. Participants of the study will be randomly operated using awake surgery or general anesthesia. In both groups intraoperative neuromonitoring will be used. Dynamics of motor functions will be assessed before and after surgery by blinded neurologists.

Interventions

PROCEDURETumor resection in awake patient

Surgeon performs critical steps of tumor removal in awake patient and controls his/her motor functions by brain mapping and assessing of voluntary movements

PROCEDURETumor resection in asleep patient

Surgeon removes tumor in asleep patient and controls his/her motor functions by brain mapping

Sponsors

Sklifosovsky Institute of Emergency Care
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Dynamics of motor function before, within 10 days after surgery and in 3 months after surgery will be assessed by neurosurgeon blinded for the treatment arm

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* single gliomas without contrast enhancement in preoperative magnetic resonance imaging (presumed low-grade gliomas) * single gliomas with contrast enhancement in preoperative magnetic resonance imaging (presumed high-grade gliomas) * one or several brain metastases from any cancer * location near primary motor area or corticospinal tract * newly diagnosed * Karnofsky Performance Status 60-100% * muscle strength in assessed limbs 3-5 points in Medical Research Council scale * age 18-69 years * body mass index 29 and less * hemoglobin 110 and more * platelets 100 and more * international normalized ratio less than 2,0 * presumed blood loss no more than 8-10 percents of circulating blood volume (no more than 450-650 milliliters)

Exclusion criteria

* chronic obstructive pulmonary disease * persistent smoker (smoking index 11 and more) * major comorbidities * implanted pacemaker * inability to perform intraoperative tests before surgery * severe aphasia * psychiatric disorders * barely controlled seizures * contraindications to magnetic resonance imaging * previously performed brain radiotherapy * pregnancy * breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Composite event of deterioration of early motor function, severe disturbance of consciousness or death from any causewithin 10 days after surgeryMotor function is assessed in Medical Research Council scale and is compared before and after surgery, deterioration of motor function means decline of 1 grade or more; level of consciousness is assessed in Glasgow Coma scale, it's severe disturbance means decline to 9 points or less
Dynamics of early motor function (in grades)within 10 days after surgeryEarly motor function is assessed in Medical Research Council scale and is compared before and after surgery
Dynamics of late motor function (in grades)in 3 months after surgeryLate motor function is assessed in Medical Research Council scale and is compared before and in 3 months after surgery

Secondary

MeasureTime frameDescription
Early Karnofsky performance status (in percents)within 10 days after surgeryAssesses patients' possibilities to self-service in Karnofsky Performance Status scale
Extent of resection (in percents)within 48 hours after surgeryExtent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100
Gross total resection (Yes or No)within 48 hours after surgeryAbsence of tumor tissue in postoperative magnetic resonance imaging
Duration of surgery (in minutes)IntraoperativelyDuration of surgery from skin incision till last skin suture
Intraoperative blood loss (in milliliters)IntraoperativelyBlood loss from skin incision till last skin suture
Late speech function (in grades)in 3 months after surgeryLate speech function is assessed in Hendrix scale (2017)
Duration of hospital stay (in days)From admission to the hospital till hospital discharge, up to 365 daysHow long patient was treated in the hospital from admission till discharge
Cerebral complicationswithin 3 months after surgeryWhich cerebral complications arose after surgery
Somatic complicationsFrom admission to intensive care unit after surgery till hospital discharge, up to 365 daysWhich somatic disorders arose after surgery
Repeated hospital admission (Yes or No)within 3 months after surgeryWhether repeated hospital admissions were required due to postoperative complications
Late Karnofsky performance status (in percents)in 3 months after surgeryAssessment of patients' possibilities to self-service in Karnofsky Performance Status scale
Duration of stay in intensive care unit (in days)From admission to intensive care unit after surgery till transfer to neurosurgical unit, up to 365 daysHow long patient was treated in intensive care unit
Composite event of deterioration of early speech, severe disturbance of consciousness or death from any causewithin 10 days after surgerySpeech function is assessed in Hendrix scale (2017) and is compared before and after surgery, deterioration of speech function means decline of 1 grade or more; level of consciousness is assessed in Glasgow Coma scale, it's severe depressing means decline to 9 points or less
Early speech function (in grades)within 10 days after surgeryEarly speech function is assessed in Hendrix scale (2017)

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026